Deep Dive

Views & Analysis
Health-Prize-Technologies_banner_570x320

Non-adherence: pharma’s final financial frontier

No other industry would tolerate avoidable annual losses of $637 billion, but that’s exactly what pharma is doing by not investing in adherence. Now is the time to start recovering that revenue.

Views & Analysis
Kantar_banner_570x320

Uncovering patient-centred insights

There are good reasons why patient centricity has become such a well-used term within the pharmaceutical industry. But, says Kantar Health’s Linda VerPlanck, the research approaches underpinning it must be able to deliver transformational insights that can, in turn, improve real-world outcomes.

Views & Analysis
David-Mitchell_banner_570x320

Interview: David Mitchell of Patients For Affordable Drugs

In the latest edition of our Deep Dive magazine - Deep Dive: Patient Centricity II - David Mitchell, President of Patients For Affordable Drugs, speaks to pharmaphorum’s Andrew McConaghie about why the organisation was set up and why its campaigning work is so important for patients.